NASDAQ
No price data available for this timeframe.
Axsome Therapeutics, Inc. (AXSM) has a price/sales ratio of 14.23x as of Friday, May 22, 2026. This represents a 34.23% decrease compared to its 12-month average of 21.64x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.